Early breast cancer: LHRH agonists show considerable promise
Tuesday, October 7, 2008 - 18:56
in Health & Medicine
Women who have had early stage breast cancer surgically removed, and whose tumour cells are stimulated by the hormone oestrogen, can benefit from taking Luteinising hormone releasing hormone (LHRH) antagonists, a Cochrane Systematic Review has concluded. This medication may be taken alone or alongside the use of tamoxifen...
Read the whole article on Science Centric
More from Science Centric
Related
- Early breast cancer: LHRH agonists show considerable promiseTue, 7 Oct 2008, 19:35:58 EDT
- Goserelin improves long-term survival in premenopausal women with early breast cancerTue, 24 Feb 2009, 18:16:24 EST
- Test for hormones in blood not reflective of hormones in breast tissue; breast cancer riskWed, 22 Apr 2009, 10:44:53 EDT
- Long-term hormone replacement therapy increases breast cancer riskWed, 28 May 2008, 10:07:27 EDT
- New evidence of hormone therapy causing breast cancer, Stanford professor saysWed, 4 Feb 2009, 17:44:21 EST